Bone Mineral Density in Adults With Hyperphenylalaninemia on Kuvan Therapy

Key facts

Sponsor

The University of Texas Health Science Center, Houston

Principal Investigator

Heather W Saavedra, MS, MD

The University of Texas Health Science Center, Houston

Intervention

Sapropterin(drug)

Enrollment

6 enrolled

Eligibility

18-50 years · All sexes

Timeline

2011 – 2012

Study locations (1)

• The University of Texas Health Science Center at Houston, Houston, Texas, United States

Collaborators

BioMarin Pharmaceutical

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Classic phenylketonuria

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE1NCT07241234
  A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria
  Agios Pharmaceuticals, Inc.
• RECRUITINGNANCT07526909
  Effect of Different Meal Types Given Before Exercise on Plasma Amino Acid Levels and Metabolic Control Parameters in Classical Phenylketonuria Patients Undergoing Aerobic and Resistance Exercises
  Hacettepe University
• ACTIVE NOT RECRUITINGPHASE4NCT06780332
  Rapid Drug Desensitization Study in Adults Experiencing Hypersensitivity Reactions to Palynziq
  BioMarin Pharmaceutical
• RECRUITINGNANCT01659749
  Educational, Social Support, and Nutritional Interventions and Their Cumulative Effect on Pregnancy Outcomes and Quality of Life in Teen and Adult Women With Phenylketonuria
  Emory University

See all trials for Classic phenylketonuria →